Can iPSCs Turn Back Time? Prospects and Pitfalls in Age Reversal.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing preclinical mechanisms and cellular studies with no original human data.
PubMed 40735996 · doi:10.2174/011574888X400606250721112037
What was done
This review synthesized findings from studies on induced pluripotent stem cell (iPSC)-based age reversal, focusing on mechanisms, therapeutic potential, and translational challenges associated with transient or cyclic expression of Yamanaka factors (OCT4, SOX2, KLF4, MYC).
What was found
The abstract reports no numerical findings or statistical measures. Conceptually, partial reprogramming was reported to restore youthful gene expression, DNA methylation patterns, and mitochondrial function while decreasing senescence markers, balanced against safety hurdles such as tumorigenesis, genomic instability, and loss of cellular identity.
Why it matters
It summarizes the therapeutic potential and current biological constraints of partial cellular reprogramming as an anti-aging strategy.
Limits
The abstract describes a narrative review with no quantitative meta-analysis, sample size, or new primary data. All reported mechanisms derive from preclinical and laboratory models, leaving long-term safety, optimal dosing protocols, and human efficacy unestablished.
Cited by
- supports Cellular reprogramming resets damaged mitochondria back to a younger, better-functioning state.